Rebuya, Madilyn P.

HRN: 27-74-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/05/2026
06/12/2026
IV
500mg
Q 8
Aspiration Pneumonia
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: